van der Neut et al., Recueil des Travaux Chimiques des Pays-Bas, 1953, vol. 72, p. 365,368,375
作者:van der Neut et al.
DOI:——
日期:——
PROTECTIVE EFFECT OF DMPC, DMPG, DMPC/DMPG, EGPG, LYSOPG AND LYSOPC AGAINST DRUGS THAT CAUSE CHANNELOPATHIES
申请人:Signpath Pharma Inc.
公开号:EP3151837A1
公开(公告)日:2017-04-12
[EN] PROTECTIVE EFFECT OF DMPC, DMPG, DMPC/DMPG, EGPG, LYSOPG AND LYSOPC AGAINST DRUGS THAT CAUSE CHANNELOPATHIES<br/>[FR] EFFET PROTECTEUR DE DMPC, DMPG, DMPC/DMPG, EGPG, LYSOPG ET LYSOPC CONTRE DES MÉDICAMENTS PROVOQUANT DES CANALOPATHIES
申请人:SIGNPATH PHARMA INC
公开号:WO2015187883A1
公开(公告)日:2015-12-10
The present invention includes compositions and methods for preventing one or more cardiac channelopathies or conditions resulting from irregularities or alterations in cardiac patterns caused by an active agent or a drug in a human or animal subject comprising: an amount of a lysophosphatidyl compound adapted for oral administration effective to reduce or prevent one or more cardiac channelopathies or conditions resulting from irregularities or alterations in cardiac patterns caused by the active agent or drug. Such compositions may further comprise a monoglyceride, a free fatty acid or a combination of the foregoing, including, e.g., a eutectic mixture.
Synthesis and immunostimulatory activity of 4-acyloxybutyl-1-phosphates
作者:P. A. Luk'yanov、V. I. Gorbach、T. F. Solov'eva、Yu. S. Ovodov